Hanesbrands Inc (NYSE:HBI) delivered strong third-quarter results, exceeding the high-end of their guidance range for gross margin, operating profit, and earnings per share. The company generated ...

HanesBrands (HBI) ended the recent trading session at $7.08, demonstrating a -1.39% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.05%.

Berkshire Hathaway Inc. Cl A 0.22% $1.01T Berkshire Hathaway Inc. Cl B 0.39% $1.01T VF Corp.-1.33% $7.89B Under Armour Inc. Cl C 2.09% $3.94B Under Armour Inc. Cl A 2.40% $3.94B ...

Good day, and thank you for standing by. Welcome to the Hanesbrands' Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Data supporting the potential for innovative combinations like HBI-8000 and nivolumab to reshape the future of melanoma treatment will be presented at the Society for Immunotherapy of Cancer Annual ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

FAA data valid effective Oct 31 2024 - Nov 28 2024 (unless otherwise noted).